OBJECTIVE: To establish the prevalence of foot ulceration in patients with rheumatoid arthritis (RA) in secondary care. METHODS: A postal survey of all patients with RA (n = 1,130) under the care of rheumatologists in Bradford, West Yorkshire, UK was performed. The prevalence data were validated through clinical examination, case-note review, and contact with health professionals. The false-negative rate was investigated in a subsample of patients (n = 70) who denied any history of ulceration. RESULTS: The postal survey achieved a 78% response rate. Following validation, the point prevalence of foot ulceration was 3.39% and the overall prevalence was 9.73%. The false-positive rate was initially high at 21.21%, but use of diagrammatic questionnaire data to exclude leg ulceration reduced the rate to 10.76%. The false-negative rate was 11.76%. The most common sites for ulceration were the dorsal aspect of hammer toes, the metatarsal heads, and the metatarsophalangeal joint in patients with hallux abducto valgus, with 33% of patients reporting multiple sites of ulceration. Patients with open-foot and healed-foot ulceration had significantly longer RA disease duration, reported significantly greater use of special footwear, and had a higher prevalence of foot surgery than ulcer-free patients. CONCLUSION: Foot ulceration affects a significant proportion of patients with RA. Further work is needed to establish risk factors for foot ulceration in RA and to target foot health provision more effectively.
OBJECTIVE: To establish the prevalence of foot ulceration in patients with rheumatoid arthritis (RA) in secondary care. METHODS: A postal survey of all patients with RA (n = 1,130) under the care of rheumatologists in Bradford, West Yorkshire, UK was performed. The prevalence data were validated through clinical examination, case-note review, and contact with health professionals. The false-negative rate was investigated in a subsample of patients (n = 70) who denied any history of ulceration. RESULTS: The postal survey achieved a 78% response rate. Following validation, the point prevalence of foot ulceration was 3.39% and the overall prevalence was 9.73%. The false-positive rate was initially high at 21.21%, but use of diagrammatic questionnaire data to exclude leg ulceration reduced the rate to 10.76%. The false-negative rate was 11.76%. The most common sites for ulceration were the dorsal aspect of hammer toes, the metatarsal heads, and the metatarsophalangeal joint in patients with hallux abducto valgus, with 33% of patients reporting multiple sites of ulceration. Patients with open-foot and healed-foot ulceration had significantly longer RA disease duration, reported significantly greater use of special footwear, and had a higher prevalence of foot surgery than ulcer-freepatients. CONCLUSION: Foot ulceration affects a significant proportion of patients with RA. Further work is needed to establish risk factors for foot ulceration in RA and to target foot health provision more effectively.
Authors: Adlene J Jebakumar; Prabhu D Udayakumar; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson Journal: J Rheumatol Date: 2014-01-15 Impact factor: 4.666
Authors: Jill Firth; Robin Waxman; Graham Law; E Andrea Nelson; Philip Helliwell; Heidi Siddle; Simon Otter; Violet Butters; Lesley Baker; Rosemary Hryniw; Sarah Bradley; Lorraine Loughrey; Begonya Alcacer-Pitarch; Samantha Davies; Jennifer Tranter Journal: Clin Rheumatol Date: 2013-12-06 Impact factor: 2.980
Authors: Andres Reinoso-Cobo; Pekka Anttila; Ana Belen Ortega-Avila; Pablo Cervera-Garvi; Eva Lopezosa-Reca; Ana Marchena-Rodriguez; Laura Ramos-Petersen; Gabriel Gijon-Nogueron Journal: Int J Med Sci Date: 2021-03-30 Impact factor: 3.738
Authors: Heidi J Siddle; Anthony C Redmond; Robin Waxman; Abigail R Dagg; Begonya Alcacer-Pitarch; Richard A Wilkins; Philip S Helliwell Journal: Clin Rheumatol Date: 2012-12-18 Impact factor: 2.980